Inside the study for a remedy to fight Congo's deadliest Ebola outbreak

The drug is targeted at Bundibugyo virus, which is responsible for the fast-moving outbreak and is without an approved vaccine or treatment. The trial began in July and is one of…

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.pbs.org)